SlideShare une entreprise Scribd logo
1  sur  24
- a neurological
syndrome.
EPIDEMILOGY








In India there is a low prevalence of
Parkinson’s disease. We find it in Parsi
community of Mumbai.
Even though we find early onset of PD and
may even be seen due to mutations.
In ancient India Mucuna pruriens was in used
in the treatment of PD.
But worldwide PD is found in 6 million people.
Neurological disorders reduce the quality of
life.
ETIOLOGY:They are of following types:1.primary75%
2.secondary.25%
1.Primary:
a) They may due to genetic causes. The
mutation in alpha-synuclein, parkin,
UCH1, DJ1, PINK1, LRKK cause PD
cause oxidative stress on mitochondria.
This in turn leads to nigrostriatal death.
b) Some environmental factors.

Secondary causes:1.vascular diseases:-
2.Infectious and post infectious.
Eg:- lyme disease is caused by 3
types of bacteria belonging to
genus borrelia.
Neurosyphilis and AIDS.
 Some toxins such as Mn, cyanide,
methanol, carbon monoxide, pesticides.
 And some medications such as
methyldopa, CCB, lithium and dopamine
depleting agents such as reserpine.
 Rarely it is also due hyoparathyroidsm
due to basal ganglia calcification,
repeated trauma , etc.

PATHOPHYSIOLOGY:Basal ganglia consists of:1.corpus sriatum(caudate nucleus
and putamen).
2.Globus pallidus.
3.Substantia nigra.
*They mediate the extrapyramidal motor
activity.

Basal ganglia
Extrapyramidal surface of brain:
The cerebral
cortex and the
substantia nigra
both project
towards corpus
straitum.
The corpus
striatum(caudat
e nucleus and
putmen)
projects into
globus pallidus
to thalamus and
they regulates
involuntary
movement.
 The

nigro striatal neurons make motor
connections to corpus striatum by 2
types of neurons which contain D1
(excitatory) and D2(inhibitory)
receptors.
 The D1 (excitatory) are glutaminergic
and D2 (inhibitory) are
GABAminergic.
 D1=excitatory

receptors=
acetylcholine as
transmitter=direct.
 D2=inhibitory
receptors=dopamine as
transmitter=indirect.
WHAT HAPPENS IN
PARKINSONISM?
Inhibitory component dopamine is
deficient and its concentration on basal
ganglia is low.
 There is a pathological lesion in basal
ganglia and corpus striatum.
 This occurs due to dopaminergic neuron
degeneration.
 The dopamine is deficient so D2
receptors are less stimulated.

Dopamine
deficiency
PICTURE SHOWING
SUBSTANTIA NIGRA
DEGENERATION.
As the dopaminergic
neurons have their
cell bodies in
substantial nigra. And
as the corpus
striatum receives
dopamine from
substantia nigra
degeneration of these
neurons causes
decrease in the
functional amount of
dopamine.
So eventually
Parkinsonism is due
to imbalance
between
acetylcholine and
dopamine.
Normal
levels of
dopamine
and
acetylcholi
ne
balanced.
SIGNS AND SYMPTOMS:
 Tremor

when sitting and in rest and
may be present only to one side.
 Stiff muscles and aching muscles of
leg, neck, face and other muscles of
body.
 Slow limited movement i;e
bradykinesia.
 Insomnia and nightmares are seen at
very early stage before tremor.
Person
showing
Parkinson's
disease
symptoms.
Weakness of face and throat muscles
making it harder to talk or to swallow.
 Difficulty with walking called gait
instability and postural instability.

COMPLICATIONS OF
PARKINSON’S :
 Depression

and anxiety.
 Sexual dysfunction
 Sleep disorders.
 Urinary incontience.
Parkinsonism

Contenu connexe

Tendances

Parkinsons Disease
Parkinsons DiseaseParkinsons Disease
Parkinsons Diseasetest
 
Pathophysiology of Parkinsonism
Pathophysiology of ParkinsonismPathophysiology of Parkinsonism
Pathophysiology of ParkinsonismTural Abdullayev
 
Parkinson diseases
Parkinson diseasesParkinson diseases
Parkinson diseasesN K
 
Antiparkinsoniandrugs drdhritiupdated2011drdhriti-111228115703-phpapp02
Antiparkinsoniandrugs drdhritiupdated2011drdhriti-111228115703-phpapp02Antiparkinsoniandrugs drdhritiupdated2011drdhriti-111228115703-phpapp02
Antiparkinsoniandrugs drdhritiupdated2011drdhriti-111228115703-phpapp02Dipesh Kakadiya
 
Parkinson's disease pharmacology
Parkinson's disease pharmacologyParkinson's disease pharmacology
Parkinson's disease pharmacologyZuaib Aktar
 
Parkinson's disease
Parkinson's disease Parkinson's disease
Parkinson's disease Azmath Sohail
 
Anti-Parkinson Drugs
Anti-Parkinson DrugsAnti-Parkinson Drugs
Anti-Parkinson Drugsvansh raina
 
Parkinsonism - management
Parkinsonism - managementParkinsonism - management
Parkinsonism - managementKirsha K S
 
Pharmacotherapies for parkinsons disease
Pharmacotherapies for parkinsons diseasePharmacotherapies for parkinsons disease
Pharmacotherapies for parkinsons diseaseBrian Piper
 
Parkinsons disease
Parkinsons diseaseParkinsons disease
Parkinsons diseasemmurralii
 
Anti parkinsonism drugs by dr.mahi yeruva
Anti parkinsonism drugs by dr.mahi yeruvaAnti parkinsonism drugs by dr.mahi yeruva
Anti parkinsonism drugs by dr.mahi yeruvaMahi Yeruva
 
Pharmacotherapy of parkinsons disease
Pharmacotherapy of parkinsons diseasePharmacotherapy of parkinsons disease
Pharmacotherapy of parkinsons diseaseQudsia Nuzhat
 
Understanding the Parkinson's disease
Understanding the Parkinson's diseaseUnderstanding the Parkinson's disease
Understanding the Parkinson's diseaseSyed Nayyer Alvi
 
Parkinson Disease
Parkinson DiseaseParkinson Disease
Parkinson Diseaseyuyuricci
 

Tendances (20)

Parkinsons Disease
Parkinsons DiseaseParkinsons Disease
Parkinsons Disease
 
Pathophysiology of Parkinsonism
Pathophysiology of ParkinsonismPathophysiology of Parkinsonism
Pathophysiology of Parkinsonism
 
Antiparkinsons
AntiparkinsonsAntiparkinsons
Antiparkinsons
 
Parkinson diseases
Parkinson diseasesParkinson diseases
Parkinson diseases
 
Parkinsonism final
Parkinsonism final Parkinsonism final
Parkinsonism final
 
Antiparkinsoniandrugs drdhritiupdated2011drdhriti-111228115703-phpapp02
Antiparkinsoniandrugs drdhritiupdated2011drdhriti-111228115703-phpapp02Antiparkinsoniandrugs drdhritiupdated2011drdhriti-111228115703-phpapp02
Antiparkinsoniandrugs drdhritiupdated2011drdhriti-111228115703-phpapp02
 
Parkinson by amir
Parkinson by amirParkinson by amir
Parkinson by amir
 
Parkinsonism
ParkinsonismParkinsonism
Parkinsonism
 
Parkinson's disease pharmacology
Parkinson's disease pharmacologyParkinson's disease pharmacology
Parkinson's disease pharmacology
 
Parkinson's disease
Parkinson's disease Parkinson's disease
Parkinson's disease
 
Anti-Parkinson Drugs
Anti-Parkinson DrugsAnti-Parkinson Drugs
Anti-Parkinson Drugs
 
Parkinsonism - management
Parkinsonism - managementParkinsonism - management
Parkinsonism - management
 
Parkinson’s disease
Parkinson’s diseaseParkinson’s disease
Parkinson’s disease
 
Pharmacotherapies for parkinsons disease
Pharmacotherapies for parkinsons diseasePharmacotherapies for parkinsons disease
Pharmacotherapies for parkinsons disease
 
Parkinsons disease
Parkinsons diseaseParkinsons disease
Parkinsons disease
 
Anti parkinsonism drugs by dr.mahi yeruva
Anti parkinsonism drugs by dr.mahi yeruvaAnti parkinsonism drugs by dr.mahi yeruva
Anti parkinsonism drugs by dr.mahi yeruva
 
Parkinsonism
ParkinsonismParkinsonism
Parkinsonism
 
Pharmacotherapy of parkinsons disease
Pharmacotherapy of parkinsons diseasePharmacotherapy of parkinsons disease
Pharmacotherapy of parkinsons disease
 
Understanding the Parkinson's disease
Understanding the Parkinson's diseaseUnderstanding the Parkinson's disease
Understanding the Parkinson's disease
 
Parkinson Disease
Parkinson DiseaseParkinson Disease
Parkinson Disease
 

En vedette

Spect in parkinsonism
Spect in parkinsonismSpect in parkinsonism
Spect in parkinsonismgulabsoni
 
Ebs schwannomatosis
Ebs schwannomatosisEbs schwannomatosis
Ebs schwannomatosisMQ_Library
 
Jc eurotherm3235 ppt
Jc eurotherm3235 pptJc eurotherm3235 ppt
Jc eurotherm3235 pptMQ_Library
 
Ebs wiedmann 18.2.16
Ebs wiedmann 18.2.16Ebs wiedmann 18.2.16
Ebs wiedmann 18.2.16MQ_Library
 
IDH mutations in glioma
IDH mutations in gliomaIDH mutations in glioma
IDH mutations in gliomaMQ_Library
 
Macquarie Neurosrgery Evidence Based Surgery
Macquarie Neurosrgery Evidence Based SurgeryMacquarie Neurosrgery Evidence Based Surgery
Macquarie Neurosrgery Evidence Based SurgeryMQ_Library
 
Journal club 20_sept
Journal club 20_septJournal club 20_sept
Journal club 20_septMQ_Library
 
Anticoagulation in neurosurgery heparin warfarin_ppt
Anticoagulation in neurosurgery heparin warfarin_pptAnticoagulation in neurosurgery heparin warfarin_ppt
Anticoagulation in neurosurgery heparin warfarin_pptMQ_Library
 
Epileptogenesis - Mechanisms and Clinical Implications
Epileptogenesis - Mechanisms and Clinical ImplicationsEpileptogenesis - Mechanisms and Clinical Implications
Epileptogenesis - Mechanisms and Clinical ImplicationsRahul Kumar
 
GRADE 實證醫學 證據評比系統
GRADE 實證醫學 證據評比系統GRADE 實證醫學 證據評比系統
GRADE 實證醫學 證據評比系統人瑋 劉
 
Mmd + aneurysms ebs
Mmd + aneurysms ebsMmd + aneurysms ebs
Mmd + aneurysms ebsMQ_Library
 
Trial of Decompressive Craniectomy for Traumatic Intracranial Hypertension
Trial of Decompressive Craniectomy for Traumatic Intracranial HypertensionTrial of Decompressive Craniectomy for Traumatic Intracranial Hypertension
Trial of Decompressive Craniectomy for Traumatic Intracranial HypertensionMQ_Library
 
Reversible cerebral vasoconstriction syndrome
Reversible cerebral vasoconstriction syndromeReversible cerebral vasoconstriction syndrome
Reversible cerebral vasoconstriction syndromePrisma Health Upstate
 

En vedette (20)

Spect in parkinsonism
Spect in parkinsonismSpect in parkinsonism
Spect in parkinsonism
 
Fabi Camo
Fabi CamoFabi Camo
Fabi Camo
 
Motor tracts
Motor tractsMotor tracts
Motor tracts
 
Frontal lobe epilepsy
Frontal lobe epilepsyFrontal lobe epilepsy
Frontal lobe epilepsy
 
Ebs schwannomatosis
Ebs schwannomatosisEbs schwannomatosis
Ebs schwannomatosis
 
Jc eurotherm3235 ppt
Jc eurotherm3235 pptJc eurotherm3235 ppt
Jc eurotherm3235 ppt
 
Wiedmann ebs
Wiedmann ebsWiedmann ebs
Wiedmann ebs
 
Tfv
TfvTfv
Tfv
 
Ebs wiedmann 18.2.16
Ebs wiedmann 18.2.16Ebs wiedmann 18.2.16
Ebs wiedmann 18.2.16
 
IDH mutations in glioma
IDH mutations in gliomaIDH mutations in glioma
IDH mutations in glioma
 
Macquarie Neurosrgery Evidence Based Surgery
Macquarie Neurosrgery Evidence Based SurgeryMacquarie Neurosrgery Evidence Based Surgery
Macquarie Neurosrgery Evidence Based Surgery
 
Ebs hfs + an
Ebs hfs + anEbs hfs + an
Ebs hfs + an
 
Journal club 20_sept
Journal club 20_septJournal club 20_sept
Journal club 20_sept
 
Anticoagulation in neurosurgery heparin warfarin_ppt
Anticoagulation in neurosurgery heparin warfarin_pptAnticoagulation in neurosurgery heparin warfarin_ppt
Anticoagulation in neurosurgery heparin warfarin_ppt
 
Epileptogenesis - Mechanisms and Clinical Implications
Epileptogenesis - Mechanisms and Clinical ImplicationsEpileptogenesis - Mechanisms and Clinical Implications
Epileptogenesis - Mechanisms and Clinical Implications
 
GRADE 實證醫學 證據評比系統
GRADE 實證醫學 證據評比系統GRADE 實證醫學 證據評比系統
GRADE 實證醫學 證據評比系統
 
Image guidance in neurosurgery
Image guidance in neurosurgeryImage guidance in neurosurgery
Image guidance in neurosurgery
 
Mmd + aneurysms ebs
Mmd + aneurysms ebsMmd + aneurysms ebs
Mmd + aneurysms ebs
 
Trial of Decompressive Craniectomy for Traumatic Intracranial Hypertension
Trial of Decompressive Craniectomy for Traumatic Intracranial HypertensionTrial of Decompressive Craniectomy for Traumatic Intracranial Hypertension
Trial of Decompressive Craniectomy for Traumatic Intracranial Hypertension
 
Reversible cerebral vasoconstriction syndrome
Reversible cerebral vasoconstriction syndromeReversible cerebral vasoconstriction syndrome
Reversible cerebral vasoconstriction syndrome
 

Similaire à Parkinsonism

Parkinson's Disease [Advanced Pharmacology]
Parkinson's Disease [Advanced Pharmacology]Parkinson's Disease [Advanced Pharmacology]
Parkinson's Disease [Advanced Pharmacology]Megh Vithalkar
 
Pharmacotherapy of Neurodegenrative diseases
Pharmacotherapy of Neurodegenrative diseases Pharmacotherapy of Neurodegenrative diseases
Pharmacotherapy of Neurodegenrative diseases DrSnehaDange
 
Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...
Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...
Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...Soujanya Pharm.D
 
PARKINSON’S DISEASE
PARKINSON’S DISEASE PARKINSON’S DISEASE
PARKINSON’S DISEASE ShaistaSumayya
 
Parkinsons disease V Pharm.D
Parkinsons disease V Pharm.DParkinsons disease V Pharm.D
Parkinsons disease V Pharm.DDr.Sohel Memon
 
Week 1 Parkinson's disease (1) (1).pptx
Week 1 Parkinson's disease (1) (1).pptxWeek 1 Parkinson's disease (1) (1).pptx
Week 1 Parkinson's disease (1) (1).pptxNisar Ahmad
 
Parkinsons disease presentation v2
Parkinsons disease presentation v2Parkinsons disease presentation v2
Parkinsons disease presentation v2David Quilliam
 
Parkinsons disease presentation v2
Parkinsons disease presentation v2Parkinsons disease presentation v2
Parkinsons disease presentation v2sammyt1996
 
Parkinson's Disease
Parkinson's DiseaseParkinson's Disease
Parkinson's DiseaseSandra saju
 
PARKINSON’S DISEASE.pptx
PARKINSON’S DISEASE.pptxPARKINSON’S DISEASE.pptx
PARKINSON’S DISEASE.pptxAmeena Kadar
 
Parkinsons Disease-Decrease in neurotransmitter secretions.
Parkinsons Disease-Decrease in neurotransmitter secretions.Parkinsons Disease-Decrease in neurotransmitter secretions.
Parkinsons Disease-Decrease in neurotransmitter secretions.Fatima Aftab
 
Parkinson's disease
 Parkinson's disease Parkinson's disease
Parkinson's diseaseSunil Pahari
 
NEURODEGENERATIVE DISEASES
NEURODEGENERATIVE DISEASESNEURODEGENERATIVE DISEASES
NEURODEGENERATIVE DISEASESGomathi .S
 
Aposan-Scientific information.pptx
Aposan-Scientific information.pptxAposan-Scientific information.pptx
Aposan-Scientific information.pptxLakshyaJBasumatary
 

Similaire à Parkinsonism (20)

Parkinsonism & Azheimers
Parkinsonism & AzheimersParkinsonism & Azheimers
Parkinsonism & Azheimers
 
Parkinson's Disease [Advanced Pharmacology]
Parkinson's Disease [Advanced Pharmacology]Parkinson's Disease [Advanced Pharmacology]
Parkinson's Disease [Advanced Pharmacology]
 
Pharmacotherapy of Neurodegenrative diseases
Pharmacotherapy of Neurodegenrative diseases Pharmacotherapy of Neurodegenrative diseases
Pharmacotherapy of Neurodegenrative diseases
 
Prakash park
Prakash parkPrakash park
Prakash park
 
Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...
Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...
Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...
 
PARKINSON’S DISEASE
PARKINSON’S DISEASE PARKINSON’S DISEASE
PARKINSON’S DISEASE
 
Parkinsonism
ParkinsonismParkinsonism
Parkinsonism
 
Parkinsons disease V Pharm.D
Parkinsons disease V Pharm.DParkinsons disease V Pharm.D
Parkinsons disease V Pharm.D
 
Week 1 Parkinson's disease (1) (1).pptx
Week 1 Parkinson's disease (1) (1).pptxWeek 1 Parkinson's disease (1) (1).pptx
Week 1 Parkinson's disease (1) (1).pptx
 
Antiparkinson drugs
Antiparkinson drugsAntiparkinson drugs
Antiparkinson drugs
 
Parkinsons disease presentation v2
Parkinsons disease presentation v2Parkinsons disease presentation v2
Parkinsons disease presentation v2
 
Parkinsons disease presentation v2
Parkinsons disease presentation v2Parkinsons disease presentation v2
Parkinsons disease presentation v2
 
Parkinson's Disease
Parkinson's DiseaseParkinson's Disease
Parkinson's Disease
 
PARKINSON’S DISEASE.pptx
PARKINSON’S DISEASE.pptxPARKINSON’S DISEASE.pptx
PARKINSON’S DISEASE.pptx
 
Parkinson s disease
Parkinson s diseaseParkinson s disease
Parkinson s disease
 
Parkinsons Disease-Decrease in neurotransmitter secretions.
Parkinsons Disease-Decrease in neurotransmitter secretions.Parkinsons Disease-Decrease in neurotransmitter secretions.
Parkinsons Disease-Decrease in neurotransmitter secretions.
 
Parkinson disease
Parkinson diseaseParkinson disease
Parkinson disease
 
Parkinson's disease
 Parkinson's disease Parkinson's disease
Parkinson's disease
 
NEURODEGENERATIVE DISEASES
NEURODEGENERATIVE DISEASESNEURODEGENERATIVE DISEASES
NEURODEGENERATIVE DISEASES
 
Aposan-Scientific information.pptx
Aposan-Scientific information.pptxAposan-Scientific information.pptx
Aposan-Scientific information.pptx
 

Dernier

Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfGrade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfJemuel Francisco
 
Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4JOYLYNSAMANIEGO
 
How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17Celine George
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxHumphrey A Beña
 
Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Celine George
 
The Contemporary World: The Globalization of World Politics
The Contemporary World: The Globalization of World PoliticsThe Contemporary World: The Globalization of World Politics
The Contemporary World: The Globalization of World PoliticsRommel Regala
 
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdfInclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdfTechSoup
 
Dust Of Snow By Robert Frost Class-X English CBSE
Dust Of Snow By Robert Frost Class-X English CBSEDust Of Snow By Robert Frost Class-X English CBSE
Dust Of Snow By Robert Frost Class-X English CBSEaurabinda banchhor
 
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdfVirtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdfErwinPantujan2
 
Choosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for ParentsChoosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for Parentsnavabharathschool99
 
ROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptxROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptxVanesaIglesias10
 
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptxMULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptxAnupkumar Sharma
 
Textual Evidence in Reading and Writing of SHS
Textual Evidence in Reading and Writing of SHSTextual Evidence in Reading and Writing of SHS
Textual Evidence in Reading and Writing of SHSMae Pangan
 
Student Profile Sample - We help schools to connect the data they have, with ...
Student Profile Sample - We help schools to connect the data they have, with ...Student Profile Sample - We help schools to connect the data they have, with ...
Student Profile Sample - We help schools to connect the data they have, with ...Seán Kennedy
 
Integumentary System SMP B. Pharm Sem I.ppt
Integumentary System SMP B. Pharm Sem I.pptIntegumentary System SMP B. Pharm Sem I.ppt
Integumentary System SMP B. Pharm Sem I.pptshraddhaparab530
 
4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptxmary850239
 
How to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPHow to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPCeline George
 

Dernier (20)

Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfGrade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
 
Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4
 
How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
 
Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17
 
YOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptx
YOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptxYOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptx
YOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptx
 
The Contemporary World: The Globalization of World Politics
The Contemporary World: The Globalization of World PoliticsThe Contemporary World: The Globalization of World Politics
The Contemporary World: The Globalization of World Politics
 
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdfInclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
 
Dust Of Snow By Robert Frost Class-X English CBSE
Dust Of Snow By Robert Frost Class-X English CBSEDust Of Snow By Robert Frost Class-X English CBSE
Dust Of Snow By Robert Frost Class-X English CBSE
 
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdfVirtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
 
Choosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for ParentsChoosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for Parents
 
ROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptxROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptx
 
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptxLEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
 
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptxMULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
 
Textual Evidence in Reading and Writing of SHS
Textual Evidence in Reading and Writing of SHSTextual Evidence in Reading and Writing of SHS
Textual Evidence in Reading and Writing of SHS
 
Student Profile Sample - We help schools to connect the data they have, with ...
Student Profile Sample - We help schools to connect the data they have, with ...Student Profile Sample - We help schools to connect the data they have, with ...
Student Profile Sample - We help schools to connect the data they have, with ...
 
Integumentary System SMP B. Pharm Sem I.ppt
Integumentary System SMP B. Pharm Sem I.pptIntegumentary System SMP B. Pharm Sem I.ppt
Integumentary System SMP B. Pharm Sem I.ppt
 
4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx
 
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptxYOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
 
How to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPHow to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERP
 

Parkinsonism